PPA
INSY

Parametric Portfolio Associates’s Insys Therapeutics, Inc. INSY Stock Holding History

Parametric Portfolio Associates’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-27,351
Closed -$126K – 4040
2019
Q1 		$126K Buy
+27,351
New +$129K ﹤0.01% 3787
2018
Q4 		– Sell
-21,940
Closed -$221K – 4014
2018
Q3 		$221K Buy
21,940
+2,129
+11% +$17K ﹤0.01% 3724
2018
Q2 		$143K Buy
19,811
+318
+2% +$2.22K ﹤0.01% 3760
2018
Q1 		$118K Buy
19,493
+1,815
+10% +$15K ﹤0.01% 3841
2017
Q4 		$170K Buy
+17,678
New +$116K ﹤0.01% 3777
2017
Q3 		– Sell
-33,712
Closed -$426K – 4078
2017
Q2 		$426K Buy
33,712
+8,000
+31% +$94.7K ﹤0.01% 3455
2017
Q1 		$270K Buy
25,712
+6,600
+35% +$70.3K ﹤0.01% 3482
2016
Q4 		$176K Buy
19,112
+6,718
+54% +$75.9K ﹤0.01% 3619
2016
Q3 		$146K Sell
12,394
-2,803
-18% -$42.6K ﹤0.01% 3635
2016
Q2 		$197K Buy
15,197
+2,328
+18% +$33.9K ﹤0.01% 3615
2016
Q1 		$206K Sell
12,869
-29,597
-70% -$562K ﹤0.01% 3735
2015
Q4 		$1.22M Buy
+42,466
New +$1.18M ﹤0.01% 2632

Other funds holding INSY

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $46.3B AUM 43.9% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return

Parametric Portfolio Associates's INSY Position: Q2 2019 in Review

Parametric Portfolio Associates sold out of Insys Therapeutics, Inc. (INSY) in Q2 2019, closing a stake of 27,351 shares — an estimated $126K sold.

Parametric Portfolio Associates first reported a position in INSY in Q4 2015 and held it in 12 quarters. The position peaked at $1.22M in Q4 2015. 16 funds tracked by Wall St. Rank hold INSY as of Q2 2019.

  • Parametric Portfolio Associates reported no remaining Insys Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
  • Parametric Portfolio Associates sold 27,351 Insys Therapeutics, Inc. shares in Q2 2019, an estimated $126K.
  • Parametric Portfolio Associates first reported a position in Insys Therapeutics, Inc. in Q4 2015 and held it in 12 quarters.
  • Parametric Portfolio Associates's Insys Therapeutics, Inc. position peaked at $1.22M in Q4 2015.
  • 16 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2019.

Based on Parametric Portfolio Associates's 13F filing for Q2 2019, filed 13 Aug 2019.